Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 677

1.

Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT, Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL, Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C, Weitzel J, Moller P, Gilchrist DM, Olopade O, Ginsburg O, Sun P, Huzarski T, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Breast Cancer Res Treat. 2014 Jul;146(2):421-7. doi: 10.1007/s10549-014-3026-3. Epub 2014 Jun 21.

PMID:
24951267
[PubMed - in process]
2.

Multiple primary cancers as a guide to heritability.

Cybulski C, Nazarali S, Narod SA.

Int J Cancer. 2014 Jun 19. doi: 10.1002/ijc.28988. [Epub ahead of print]

PMID:
24945890
[PubMed - as supplied by publisher]
3.

Factors associated with breast cancer mortality after local recurrence.

Dent R, Valentini A, Hanna W, Rawlinson E, Rakovitch E, Sun P, Narod SA.

Curr Oncol. 2014 Jun;21(3):e418-25. doi: 10.3747/co.21.1563.

PMID:
24940101
[PubMed]
Free PMC Article
4.

A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.

Narod SA, Rakovitch E.

Curr Oncol. 2014 Jun;21(3):119-24. doi: 10.3747/co.21.1892.

PMID:
24940092
[PubMed]
Free PMC Article
5.

Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?

Vyarvelska I, Rosen B, Narod SA.

Gynecol Oncol. 2014 Jun 2. pii: S0090-8258(14)00980-9. doi: 10.1016/j.ygyno.2014.05.020. [Epub ahead of print] No abstract available.

PMID:
24887353
[PubMed - as supplied by publisher]
6.

Genetics of endometrial cancer.

Shai A, Segev Y, Narod SA.

Fam Cancer. 2014 May 17. [Epub ahead of print]

PMID:
24838932
[PubMed - as supplied by publisher]
7.

BRCA1 founder mutations compared to ovarian cancer in Belarus.

Savanevich A, Oszurek O, Lubiński J, Cybulski C, Dębniak T, Narod SA, Gronwald J.

Fam Cancer. 2014 Apr 27. [Epub ahead of print]

PMID:
24770866
[PubMed - as supplied by publisher]
8.

A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.

Narod SA, Tung N, Lubinski J, Huzarski T, Robson M, Lynch HT, Neuhausen SL, Ghadirian P, Kim-Sing C, Sun P, Foulkes WD; Hereditary Breast Cancer Clinical Study Group.

Curr Oncol. 2014 Apr;21(2):64-8. doi: 10.3747/co.21.1656.

PMID:
24764694
[PubMed]
Free PMC Article
9.

Risk factors for ovarian cancers with and without microsatellite instability.

Segev Y, Pal T, Rosen B, McLaughlin JR, Sellers TA, Risch HA, Zhang S, Sun P, Narod SA, Schildkraut J.

Int J Gynecol Cancer. 2014 May;24(4):664-9. doi: 10.1097/IGC.0000000000000134.

PMID:
24755492
[PubMed - in process]
10.

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.

Hernández JE, Llacuachaqui M, Palacio GV, Figueroa JD, Madrid J, Lema M, Royer R, Li S, Larson G, Weitzel JN, Narod SA.

Hered Cancer Clin Pract. 2014 Apr 17;12(1):11. doi: 10.1186/1897-4287-12-11. eCollection 2014.

PMID:
24742220
[PubMed]
Free PMC Article
11.

Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'.

Kotsopoulos J, Metcalfe K, Alston J, Nikitina D, Ginsburg O, Eisen A, Demsky R, Akbari M, Zbuk K, Narod SA.

BMC Cancer. 2014 Mar 25;14:221. doi: 10.1186/1471-2407-14-221.

PMID:
24667084
[PubMed - in process]
Free PMC Article
12.

Tamoxifen for women at high risk of breast cancer.

Nazarali SA, Narod SA.

Breast Cancer (Dove Med Press). 2014 Feb 17;6:29-36. doi: 10.2147/BCTT.S43763. eCollection 2014. Review.

PMID:
24648767
[PubMed]
Free PMC Article
13.

Response.

Narod S.

J Natl Cancer Inst. 2014 Apr;106(4):dju046. doi: 10.1093/jnci/dju046. Epub 2014 Mar 14. No abstract available.

PMID:
24634503
[PubMed - indexed for MEDLINE]
14.

A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.

McMullin RP, Wittner BS, Yang C, Denton-Schneider BR, Hicks D, Singavarapu R, Moulis S, Lee J, Akbari MR, Narod SA, Aldape KD, Steeg PS, Ramaswamy S, Sgroi DC.

Breast Cancer Res. 2014 Mar 14;16(2):R25. [Epub ahead of print]

PMID:
24625110
[PubMed - as supplied by publisher]
Free PMC Article
15.

Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.

Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T.

Genet Test Mol Biomarkers. 2014 Apr;18(4):229-35. doi: 10.1089/gtmb.2013.0393. Epub 2014 Mar 4.

PMID:
24592941
[PubMed - in process]
16.

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA.

J Clin Oncol. 2014 May 20;32(15):1547-53. doi: 10.1200/JCO.2013.53.2820. Epub 2014 Feb 24.

PMID:
24567435
[PubMed - indexed for MEDLINE]
17.

Survival from breast cancer in patients with CHEK2 mutations.

Huzarski T, Cybulski C, Wokolorczyk D, Jakubowska A, Byrski T, Gronwald J, Domagała P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Siołek M, Wiśniowski R, Janiszewska H, Surdyka D, Sibilski R, Sun P, Lubiński J, Narod SA.

Breast Cancer Res Treat. 2014 Apr;144(2):397-403. doi: 10.1007/s10549-014-2865-2. Epub 2014 Feb 21.

PMID:
24557336
[PubMed - in process]
18.

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.

Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubiński J, Cybulski C.

Clin Genet. 2014 Feb 14. doi: 10.1111/cge.12360. [Epub ahead of print]

PMID:
24528374
[PubMed - as supplied by publisher]
19.

MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers.

Baltzer HL, Alonzo-Proulx O, Mainprize JG, Yaffe MJ, Metcalfe KA, Narod SA, Warner E, Semple JL.

Ann Surg Oncol. 2014 May;21(5):1583-8. doi: 10.1245/s10434-014-3532-x. Epub 2014 Feb 14.

PMID:
24526546
[PubMed - in process]
20.

Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.

Kong I, Narod SA, Taylor C, Paszat L, Saskin R, Nofech-Moses S, Thiruchelvam D, Hanna W, Pignol JP, Sengupta S, Elavathil L, Jani PA, Done SJ, Metcalfe S, Rakovitch E.

Curr Oncol. 2014 Feb;21(1):e96-e104. doi: 10.3747/co.21.1604.

PMID:
24523627
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk